Search Within

Sasinya Neka Scott

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (45)
  2. Journal Article (25)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (70)
  2. Department of Pathology and Laboratory Medicine (70)
  3. GSK Faculty (70)
  4. Human Oncology and Pathogenesis Program (70)
  5. Surgery (52)
  6. Department of Medicine (46)

More Groups

People
  1. Michael Berger (70)
  2. David Solit (34)
  3. Bernard Bochner (29)
  4. Dean Bajorin (28)
  5. Gopakumar Iyer (28)
  6. Hikmat Al-Ahmadie (28)

More People

Years
  1. 2020 (1)
  2. 2019 (1)
  3. 2017 (4)
  4. 2016 (17)
  5. 2015 (24)
  6. 2014 (14)

More Years

Publications
  1. Modern Pathology (15)
  2. Laboratory Investigation (13)
  3. Journal of Clinical Oncology (8)
  4. Cancer Research (7)
  5. Blood (3)
  6. Cancer (2)

More Publications

Publishers
  1. Nature Publishing Group (16)
  2. Nature Research (15)
  3. American Association for Cancer Research (10)
  4. American Society of Clinical Oncology (8)
  5. Elsevier Science, Inc. (4)
  6. Wiley Blackwell (4)

More Publishers

Results (70)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next generation sequencing in effusion fluids from patients with ovarian serous carcinoma. A comparison with TCGA findings
    Meeting Abstract

    Lin, O.; Brannon, A. R.; Levine, D. A.; Arcila, M. E.; Scott, S. N.; Edelweiss, M.; Berger, M. F.
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Effective monotherapy despite intratumor heterogeneity: Clonal convergence within the PI3K pathway and sensitivity to mTOR inhibitors in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Chen, Y.; Pham, C. G.; Brannon, A. R.; Scott, S. N.; Takeda, S.; Liu, H.; Motzer, R. J.; Berger, M. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of MEK inhibitor selumetinib (AZD6244) in patients with BRAFV600E/K- or NRAS-mutated melanoma
    Meeting Abstract

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Delineating genomic heterogeneity in paired primary and metastatic colorectal cancer by massively parallel sequencing
    Meeting Abstract

    Brannon, A. R.; Vakiani, E.; Scott, S. N.; Sylvester, B.; Kania, K.; Viale, A.; Kemeny, N.; Weiser, M.; Solit, D. B.; Berger, M. F.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Pathway convergent evolution underscores treatment response to MTOR inhibitors in kidney cancers
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Detecting somatic genetic alterations in tumor specimens by exon capture and massively parallel sequencing
    Journal Article

    Won, H. H.; Scott, S. N.; Brannon, A. R.; Shah, R. H.; Berger, M. F.
    Journal of Visualized Experiments (2013)

    Fulltext@MSK | Save
  • Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma
    Journal Article

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Genetic determinants of long-term response to rapalog therapy in advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Scott, S. N.; Takeda, S.; Liu, H.; Chen, Y.; Motzer, R. J.; Berger, M. F.; Hsieh, J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Genome sequencing identifies a basis for everolimus sensitivity
    Journal Article

    Iyer, G.; Hanrahan, A. J.; Milowsky, M. I.; Al-Ahmadie, H.; Scott, S. N.; Janakiraman, M.; Pirun, M.; Sander, C.; Socci, N. D.; Ostrovnaya, I.; more...
    Science (2012)

    Fulltext@MSK | Save
  • Next-generation sequencing reveals genomic determinants of long-term response to mTOR inhibitors in patients with advanced RCC
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Brannon, A. R.; Scott, S.; Takeda, S.; Liu, H.; Chen, Y.; Motzer, R. J.; Berger, M. F.; Hsieh, J. J.
    BJU International (2012)

    Fulltext@MSK | Save